Evidence
Proof package
Translational evidence, milestone logic, and the next value-creating experiment.
For venture capital and family offices
See the operating gaps before capital has to absorb them.
AVIVA applies a consistent readiness lens across life sciences companies, then helps management close the gaps that financing alone cannot solve.
The capital challenge
Diligence can confirm the science while the company remains unprepared.
Evidence quality, IP, team coverage, regulatory timing, manufacturing, and the commercial model interact. A weakness in one area can change the capital requirement across the whole plan.
Investor Readiness
A weighted view of the company behind the asset.
AVIVA Score™ organizes diligence around the conditions required to use capital well. AVIVA refers to this internal assessment as CRI-2. The result is a scored readiness view and a sequenced gap agenda for management after the decision.
Protection
IP and patent clock
Rights, freedom to operate, remaining life, and the timing created by the portfolio.
Execution
Management coverage
The team required for the next stage, with accountable ownership for key risks.
Capital
Financeable plan
Use of funds, operating milestones, business model, and credible capital sequencing.
A portfolio lens
Compare readiness without flattening the science.
The same decision structure can be applied across a portfolio while preserving the asset-specific work that matters.
Common language
Investment and operating teams see the same readiness categories and gaps.
Clear priorities
Management receives a sequenced operating agenda tied to the next milestone.
Earlier intervention
Capital partners can see where operating support is required before delay compounds.
After the assessment
A diligence finding becomes an operating assignment.
AVIVA can work with management to close the gaps surfaced by the review. The engagement may include interim leadership, capital planning, company infrastructure, or commercial preparation.
Readiness review
Clarify the risk, operating requirement, and milestone sequence behind the financing case.
Gap closure
Assign experienced operators to the priorities that determine near-term company progress.
Readiness cadence
Reassess as evidence, team, capital needs, and commercial conditions change.
Engagement boundary
A readiness conversation is a company-building discussion.
AVIVA contributes operating expertise and readiness assessment. This site does not offer securities or request an investment commitment.